Mumbai (Maharashtra) [India], July 8 (ANI/PRNewswire): Glenmark Pharmaceuticals Limited (Glenmark), an innovation-driven global pharmaceutical company has launched sitagliptin and its Fixed Dose Combinations (FDCs), at affordable prices for adults with Type 2 diabetes in India. The company h
New Delhi [India], Sep 14 (ANI): The Ministry of Health and Family Welfare has banned the manufacture for sale, sale or distribution for human use of 328 Fixed Dose Combinations (FDCs).